Wealth Enhancement Advisory Services
AARD

Wealth Enhancement Advisory Services’s Aardvark Therapeutics AARD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.3K Buy
+10,434
New +$48.8K ﹤0.01% 3844

Other funds holding AARD

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
WETS
Wealth Enhancement Trust Services Sioux Falls, South Dakota $900M AUM
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

Wealth Enhancement Advisory Services's AARD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Aardvark Therapeutics (AARD) in Q2 2026: 10,434 shares worth $79.3K. The stake represents ﹤0.01% of the portfolio and ranks #3844 among its holdings.

9 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 10,434 shares of Aardvark Therapeutics worth $79.3K as of Q2 2026.
  • Aardvark Therapeutics was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Aardvark Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3844 holding.
  • 9 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.